Dynasty Gene

company

About

Dynasty Gene is a Developer of synthetic biology technology and provider of biotechnology consulting services.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Industries
Biotechnology,Consulting,Health Care
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Developer of synthetic biology technology and provider of biotechnology consulting services. The company focuses on technology development, technology consulting, technology transfer, and technical services in the biotechnology field, enabling their clients to make advancement in the field of next-generation DNA sequencing (NGS). The company has its own independent intellectual property rights on their Micropore high-throughput DNA synthesis platform, allowing the company to launch a series of products including: liquid biopsy solutions, NGS library capture kits, etc.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥100M
Dynasty Gene has raised a total of ¥100M in funding over 2 rounds. Their latest funding was raised on Dec 28, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 28, 2021 Series Unknown 1 ByteDance Detail
Jun 5, 2021 Series A ¥100M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Dynasty Gene is funded by 2 investors. ByteDance and Chaosheng Capital are the most recent investors.
Investor Name Lead Investor Funding Round
ByteDance Yes Series Unknown
Chaosheng Capital Series A